Cassava Sciences (SAVA) Provides Update on Government Investigations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Jones Trading Downgrades Cassava Sciences (SAVA) to Hold, 'Multiple Uncertainties'
July 1, 2024 9:43 AM EDTJones Trading analyst Soumit Roy downgraded Cassava Sciences (NASDAQ: SAVA) from Buy to Hold.
The analyst comments "Following the federal grand jury indictment of the former consultant of Cassava Sciences, Dr. Hoau-Yan Wang, last Friday (link), and today's 8-K (link) mentioning the... More
